SOLARA ACTIVE PHARMA SCIENCES LIMITED — Regulatory Filings 2021

Jul 29, 2021

Communication Address: Solara Active Pharma Sciences Limited Batra Centre

No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : investors@solara.com www.solara.co.in

July 29, 2021

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540 Scrip Code: SOLARA Dear Sirs, Sub: Newspaper advertisement

Please find enclosed copies of the newspaper advertisement titled ‘Annual General Meeting to be held over Video Conference, Record Date and Final Dividend Information’. The advertisements appeared in Business Standard and Lokmat (Marathi version).

Kindly take on record of the above.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

==> picture [146 x 39] intentionally omitted <==

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

15

MUMBAI | THURSDAY, 29 JULY 2021

~~<~~

~~.~~

(Regd. Office: PSEB Head Office, The Mall, Patiala - 147001, Corporate Identification Number (CIN) No.U40109PB2010SGC033813) Website: www.pspcl.in, Contact No. 96461-18774

TENDER ENQUIRY NO.: MQP-185/2021-22/PR

Dated: 27.07.2021

Chief Engineer/Metering, C-3, Shakti Vihar, PSPCL, Patiala, invites E-tender for procurement of 141 no, 11KV Pilfer resistant metering panel housed with 3 no. dry type 11 KV CTs conforming to IS:16227 (Part -I&II) and IEC 61869 with revised /latest amendmants, 1 no. 3- Phase Dry Type PT conforming to IS:16227 (Part - I&III) and IEC 61869 with revised/latest amendments and having meter compartment for installation of Trivector/Bivector Meter complete with wiring, cable glands etc, with accuracy of CTs as 0.2S & PT as 0.2 of 150/5. For detailed NIT and tender specification, please refer to https://eproc.punjab.gov.in from 28.07.2021 (11:00 AM onwards). Note: Corrigendum and addendum, if any will be published online at https://eproc.punjab.gov.in C 278/21 76155/12/372/2021/6295

==> picture [455 x 257] intentionally omitted <==

Franklin Templeton Mutual Fund Indiabulls Finance Center, Tower 2, 12th and 13th Floor, Senapati Bapat Marg, Elphinstone Road (West), Mumbai 400013

NOTICE

Investors may note that pursuant to Regulation 56 of Securities and Exchange Board of India (Mutual Funds) Regulations, 1996 read with SEBI Circular No. SEBI/HO/IMD/DF2/CIR/P/2018/92 dated June 5, 2018, a soft copy of the annual report of the schemes of Franklin Templeton Mutual Fund and abridged summary thereof for the period ended March 31, 2021 has been uploaded on Franklin Templeton Mutual Fund’s website (www.franklintempletonindia.com) and on the website of AMFI (https://www.amfiindia.com).

The scheme annual reports or abridged summary thereof shall also be emailed to those unitholders, whose email addresses are registered with the Mutual Fund. Unitholders can submit a request for a physical or electronic copy of the scheme wise annual report or abridged summary thereof via following modes:

Tel: 1-800-425 4255 or 1-800 -258- 4255 from 8:00 a.m. to 9:00 p.m., Monday to Saturday. E-mail: service@franklintempleton.com

For Franklin Templeton Asset Management (India) Pvt. Ltd. (Investment Manager of Franklin Templeton Mutual Fund)

Sd/Sanjay Sapre President Date: July 28, 2021

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.